Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The adverse events atlas, towards a strategy to predict synergistic adverse even...
Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands
The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies ( Prof Bart Westerman - Amsterdam UMC, Amsterdam, Netherlands )
13 Apr 2022
FAP-targeted molecular radiotherapy in cancer patients
Prof Jérémie Calais - UCLA, Los Angeles, USA
FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )
1 Apr 2022
Minimal residual disease in multiple myeloma
Prof Ola Landgren - University of Miami, Miami, USA
Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )
8 Mar 2022
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective
Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina
Real-world evidence on PET use in Hodgkin lymphoma: An Argentinian perspective ( Dr Marta Zerga - Hospital Alemán , Buenos Aires, Argentina )
3 Mar 2022
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in...
Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validation in NRG/RTOG 9408 ( Prof Daniel Spratt - University Hospitals Seidman Cancer Center, Cleveland, USA )
3 Mar 2022
Evaluating a polygenic hazard score to predict risk of developing metastatic or ...
Dr Meghana Pagadala - University of California San Diego, San Diego, USA
Evaluating a polygenic hazard score to predict risk of developing metastatic or fatal prostate cancer ( Dr Meghana Pagadala - University of California San Diego, San Diego, USA )
25 Feb 2022
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL
Dr Juliana Pereira & Dr Steven Horwitz
Brentuximab vedotin and CHP benefit over CHOP for CD30-positive PTCL ( Dr Juliana Pereira & Dr Steven Horwitz )
22 Feb 2022
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022
Update on the new EUSOMA quality indicators for breast cancer
Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022
Tumour agnostic treatments in GI cancer
Dr Nicola Normanno and Dr Katja Schmitz
Tumour agnostic treatments in GI cancer ( Dr Nicola Normanno and Dr Katja Schmitz )
1 Feb 2022
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO
Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Fr...
OncoAlert Colloquium Day 6: Gynaecological oncology, IGCS and ESO ( Dr Don Dizon, Dr Allison Betof Warner, Dr Giancarlo Pruneri, Dr Pierfrancesco Franco & Dr Kathleen Schemeler )
19 Jan 2022
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more
Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla...
OncoAlert Colloquium Day 5: SWOG, OncoAlliance and more ( Dr John Haanen, Dr Vivek Subbiah, Dr Christian Rolfo, Dr Jessica Hwang, Dr Nagla Karim, Dr Fumiko Chino, Dr Narjust Duma & Dr Nicole Kuderer )
19 Jan 2022